ACTA, along with Bellberry, the George Institute and NHMRC Clinical Trials Centre (NHMRC CTC) were the founding members of CT:IQ. This initiative is complementary to all of the aforementioned organisations and should be viewed as a collaborative platform of which ACTA is one, very important, voice representing clinical trials networks. Our vision is to act as a platform for all stakeholder voices to come together and continually improve the clinical trials field in Australia, enabling efficient and effective, patient-centred, clinical trials.
The project scoping undertaken by CT:IQ will ensure full and detailed landscape analysis to ensure that the projects conducted are either filling genuine and critical gaps, or where appropriate directly supports, advocates and dovetails with existing projects being done by ACTA and other organisations in this field.